Molecular Genetics and Metabolism Reports (Mar 2015)

ALG11-CDG: Three novel mutations and further characterization of the phenotype

  • L. Regal,
  • P.M. van Hasselt,
  • F. Foulquier,
  • I. Cuppen,
  • HCMT Prinsen,
  • K. Jansen,
  • L. Keldermans,
  • L. De Meirleir,
  • G. Matthijs,
  • J. Jaeken

DOI
https://doi.org/10.1016/j.ymgmr.2014.11.006
Journal volume & issue
Vol. 2, no. C
pp. 16 – 19

Abstract

Read online

We report on two novel patients with ALG11-CDG. The phenotype was characterized by severe psychomotor disability, progressive microcephaly, sensorineural hearing loss, therapy-resistant epilepsy with burst suppression EEG, cerebral atrophy with, in one of them, neuronal heterotopia, and early lethality. Analysis of ALG11 revealed compound heterozygosity involving three novel mutations: the splice site mutation c.45-2A > T, the c.36dupG duplication, and the missense mutation c.479G > T (p.G160V) that was present in both.

Keywords